Navigation Links
Validant Names Michael Beatrice as New Company President
Date:5/2/2013

SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- Today, Validant, a leading Quality and Regulatory services firm to global biotechnology, pharmaceutical, and medical device companies, named Michael Beatrice , PhD, as company President.

In this role, Mike will assume oversight of all existing client operations and lead the design and development of future service offerings.

"Mike will draw from his broad experience and strong leadership qualities to contribute significantly to Validant's current engagements.  In addition, his vision will direct Validant's next generation of products and services…" Brian Healy , CEO.

Prior to joining Validant, Mike spent the past thirteen years as Corporate Vice President, Abbott Quality and Regulatory, Abbott Laboratories.

Prior to that, he spent more than 20 years at the Food and Drug Administration (FDA), including three years as the Deputy Director of the Center for Biologics Evaluation and Research (CBER).

Beatrice holds a Bachelors of Science degree in pharmacy from the University of New Mexico, a Master of Science degree in pharmacy/biopharmaceutics from University of Oklahoma and a PhD in Pharmaceutics / Pharmaceutical Manufacturing from the University of Maryland.

About Validant

Validant is a leading Quality and Regulatory services firm to the regulated life sciences manufacturing industry.  With a proven track record of hundreds of successful client engagements with Fortune 500 companies, including 7 of the top 10 biotechnology, pharmaceutical and medical device companies, Validant has differentiated itself as the premier partner for clients looking to leverage the largest network of quality, regulatory, manufacturing and engineering professionals in the country.  More information is available at www.validant.com.


'/>"/>
SOURCE Validant
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
2. TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
3. BIOCOM Names Rick Fultz Vice President of Business Development
4. Bayer CropScience Names Jeremy Jack 2013 Young Sustainable Farmer at Ag Issues Forum
5. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
6. Quantason Names Dr. Ellen B. Mendelson, Medical Director
7. Nano Mask Names Dr. Hassan Bennani to Board of Directors
8. SPIE Names 69 New Fellows of the Society in 2013
9. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
10. AtheroNova Names New Director
11. FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Diego, CA (PRWEB) , ... March 29, 2017 ... ... develops cutting edge instrumentation for cell-based assays, disperses a quarterly travel award to ... conferences. Today the company announced that its new round of awards are ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a company ... world’s food supply through enhancement of the gut microbiota, today announced the closing of ... Innovations , New York-based Sustainable Income Capital Management, LLC and a number of private ...
(Date:3/29/2017)... and NEWARK, Del. , March 29, ... regenerative medicine company, and W. L. Gore ... today announced a collaborative research agreement whereby the two ... therapy delivery device technologies that provide protection from immune ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:3/29/2017)... Limited (TSX:GEN) ("GeneNews" or the "Company") announced today the ... for breast cancer, via its Virginia -based ... blood-based biomarker test with a sophisticated algorithm to determine a ... ... measures the fasting plasma levels of two biomarkers in the ...
Breaking Biology Technology:
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
Breaking Biology News(10 mins):